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   Pediatric brain tumors are a significant threat to the health of thousands of children in the U.S. today. As the most common solid tumor diagnosis in children, pediatric brain tumors constitute 20‐25% of all childhood malignancies (Panigraphy & Bluml, 2009) and are the second leading cause of death by disease in children (Central Brain Tumor Registry 
of the United States; CBTRUS, 2011). CNS tumor diagnoses occur at a rate of 4.3 cases per 100,000 children, making them the second leading pediatric cancer diagnosis (Nathan, 
Patel, Dilley, Goldsby, Harvey, Jacobsen et al., 2007; Gottardo & Gajjar, 2008). Brain tumor diagnoses are heterogeneous; over 100 subtypes of pediatric brain tumors exist, with the most common being medulloblastomas, pilocytic astrocytomas, and ependyomas (Panigraphy & Bluml, 2009). Despite the prevalence of brain tumor diagnoses among children, 5‐year survival rates have increased to 74% in children diagnosed below 20 years of age (Nathan et al., 2010). Improvement in survival is largely due to modifications in treatment protocols, with many patients receiving a combination of surgery, radiation, and chemotherapy (Gotardo & Gajjar, 2008). As survival rates for pediatric brain tumor patients continue to rise, increasing focus has turned to improving the long‐term quality life for these children.     There are costs associated with effective treatment, as many survivors experience limitations in physical performance, endocrine function, and cardiac impairment in the years following recovery (Ness & Gurney, 2007). Even more, for many pediatric brain tumor survivors, the late effects of treatment extend to impairments in neurocognition and increases in emotional problems. Neurocognitive effects are pervasive, with studies reporting 40‐100% of survivors experiencing some form of cognitive deficit following treatment (Glauser & Packer, 1991). Affected cognitive domains include overall intelligence, 
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Table 1  
Demographics of BT Survivors and Healthy Controls 
Variables       BT     Healthy Control  χ2 (p) 
 
Sex  
     Female    12 (60%)  9 (45%)  .90 (.34) 
     Male    8 (40%)  11 (55%) 
 
Race/ethnicity (n, %) 
     White/Caucasian   18 (90%)  12 (60%)  5.77 (.12) 
     Black/African American   1 (5%)   6 (30%)   
     Latino     0     1 (5%) 
     Asian/ Pacific Islander   1 (5%)   1 (5%) 
 
Primary Caregiver (n, %) 
     Mother    17 (85%)  20 (100%)  3.24 (.072) 
     Father     3 (15%)   0 
 
Parent Education (n, %) 
    ≤ High School Graduation  4 (20%)   0   4.44 (.04)* 
    > High School Graduation   16 (80.%)  20 (100%) 
 
Household Income 
     <$50,000/year     8 (40%)  9 (45%)  1.06 (.59) 
     ≥$50,000/year   11 (55%)  11 (55%) 
     Rather Not Say   1 (5%)   0 
Age at Enrollment (in years)      
     Mean (SD)    12.15 (2.72)  12 (2.98)  5.69 (.68) 






Descriptive Statistics: BRIEF, WISC, RSQ, YSR, CBCL, BOLD 





Mean (SD) t (p) 
BRIEF Working Memory Scale 61.60 
(12.91) 
53.15 (11.60) 2.177 (.04)* 
WISC-IV WMI Composite Score 90.10 
(12.33) 
101.05 (12.44) -2.80 (.01)** 
RSQ Scales    
Primary Control Engagement .17 (.06) .20 (.06) -1.81 (.08) 
Secondary Control Engagement .28 (.17) .26 (.07) .59 (.56) 
Disengagement .14 (.05) .16 (.02) -.99 (.33) 
Emotional/Behavioral Outcomes    
YSR Anxious/Depressed 57.63 
(10.31) 
54.32 (4.42) 1.29 (.21) 
CBCL Anxious/Depressed 58.9 (8.01) 55.35 (9.63) 1.27 (.21) 
YSR Withdrawn/Depressed 58.63 
(8.71) 
55.05 (5.45) 1.52 (.14) 
CBCL Withdrawn/Depressed 60.50 
(8.00) 
54.00 (5.13) 3.06 (.00)** 
N-Back Variables    
3v0-Back: Cluster 19 – BA 32 .02 (.22) .21 (.18) -2.71 (.01)** 
0-Back Accuracy 43.56 
(2.73) 
44.47 (1.94) -1.11 (.26) 
1-Back Accuracy 43.33 
(2.83) 
44.59 (1.46) -1.63 (.11) 
2-Back Accuracy 41.50 
(2.55) 
42.35 (3.02) -.91 (.37) 
3-Back Accuracy 37.50 
(2.60) 
40.41 (2.37) -3.46 (.00)** 
Note: T Scores were used in these analyses; Higher scores on the BRIEF indicate poorer 
performance 






    1. 2. 3. 4. 5. 6. 7. 8. 9.
 10. 11.  
 
1. BT or HC                              --                                                          
2. BRIEF WM Scale                            -.33*           --                     
      
3. WISC WMI Composite               .41**       -.44**        --              
4. RSQ – Primary Control                    .28           -.03         .41** --              
5. RSQ – Secondary Control              -.10           .17         -.33*          -.24            --             
6. RSQ - Disengagement               .16          -.41**      .38*           .29           -.34*          --  
7. YSR Anxious/Depressed               -.21           .03         -.14            -.27         -.37*        .40* --   
8. CBCL Anxious/Depressed              -.20           .28         -.26            -.15            .12          .02          .24         --          
9. YSR Withdrawn/Depressed            -.25           .05          .05            -.28           -.28          .34*        .74*       .047           --  
10. CBCL Withdrawn/Depressed       -.45**       -.40*      -.26            -.09            .28          -.07         .13         .60**        .18            
--  
11. 3v0 Back Cluster 19 – BA 32        .44*         -.28        .20               .08           -.05          -.07         .07        -.24            .29          -













Regression Equation Testing 3v0 BOLD activation for BA 32 as Dependent Variable Step  Predictors  β  t(p)  R2  R2 ‐Change  F‐Change Step 1: WISC‐IV WMI  WMI  ‐.004  ‐2.44*  .17  .17  5.95 Step 2:  Group  WMI  ‐.004  ‐2.055*  .17  .001  .03 Group  ‐.008  ‐.17 Step 3: Secondary Control Coping  WMI  ‐.003  .911  .20  .04  1.25 Group  .02  ‐1.57 RSQ Secondary  .004  .30 Step 4:  CBCL Withdrawn/Depressed  WMI  ‐.003  .91  .21  .004  .12 Group  .009  ‐1.54 RSQ Secondary  .004  .15 CBCL W/D  .039  1.12 *p≤.05, **p≤.01, ***p≤.001    
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